These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9839101

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
    Papademetriou V, Gottdiener JS, Narayan P, Cushman WG, Zachariah PK, Gottdiener PS, Chase GA.
    J Am Coll Cardiol; 1997 Dec; 30(7):1802-8. PubMed ID: 9385910
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS).
    Grimm RH, Flack JM, Byington R, Bond G, Brugger S.
    Drugs; 1990 Dec; 40 Suppl 2():38-43. PubMed ID: 2150640
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research Group.
    Furberg CD, Byington RP, Borhani NA.
    Am J Med; 1989 Apr 17; 86(4A):37-9. PubMed ID: 2523653
    [Abstract] [Full Text] [Related]

  • 8. MIDAS: hypertension and atherosclerosis. A trial of the effects of antihypertensive drug treatment on atherosclerosis. MIDAS Research Group.
    Borhani NO, Miller ST, Brugger SB, Schnaper HW, Craven TE, Bond MG, Khoury S, Flack J.
    J Cardiovasc Pharmacol; 1992 Apr 17; 19 Suppl 3():S16-20. PubMed ID: 1376828
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Multicenter Isradipine/Diuretic Atherosclerosis Study: a study of the antiatherogenic properties of isradipine in hypertensive patients. MIDAS Research Group.
    Borhani NO, Bond MG, Sowers JR, Canossa-Terris M, Buckalew V, Gibbons ME, Worthy AJ.
    J Cardiovasc Pharmacol; 1991 Apr 17; 18 Suppl 3():S15-9. PubMed ID: 1720479
    [Abstract] [Full Text] [Related]

  • 13. Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
    Silagy CA, McNeil JJ, McGrath BP.
    Am J Cardiol; 1992 Nov 15; 70(15):1299-305. PubMed ID: 1442581
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women.
    Perry HM, Hall WD, Benz JR, Bartels DW, Kostis JB, Townsend RR, Due DL, Peng A, Sirgo M.
    Am J Med; 1994 Jan 15; 96(1):77-86. PubMed ID: 8304366
    [Abstract] [Full Text] [Related]

  • 20. MIDAS: rationale, design and descriptive data of trial patients. The MIDAS Research Group.
    Borhani NO.
    Blood Press Suppl; 1994 Jan 15; 1():29-35. PubMed ID: 8205295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.